Phase I Study in Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Patients to Determine the Recommended Dose of the Investigational Product (CYAD-02)

A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high‐risk myelodysplastic syndrome

American Journal of Hematology ◽

10.1002/ajh.25958 ◽

2020 ◽

Vol 95 (12) ◽

pp. 1457-1465

Author(s):

Caner Saygin ◽

Karilyn Larkin ◽

James S. Blachly ◽

Shelley Orwick ◽

Apollinaire Ngankeu ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Myelodysplastic Syndrome ◽

Phase I ◽

Myeloid Leukemia ◽

Phase I Study ◽

Fatal Hepatic Veno-Occlusive Disease in a Phase I Study of Mylotarg and Troxatyl in Patients with Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Acta Haematologica ◽

10.1159/000064700 ◽

2002 ◽

Vol 108 (3) ◽

pp. 164-167 ◽

Cited By ~ 9

Author(s):

Francis Giles ◽

Guillermo Garcia-Manero ◽

Susan O’Brien ◽

Elihu Estey ◽

Hagop Kantarjian

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Phase I ◽

Myeloid Leukemia ◽

Phase I Study ◽

Occlusive Disease ◽

Phase I study of GTI-2040, a ribonucleotide reductase antisense, with high dose cytarabine in patients with relapsed/refractory acute myeloid leukemia

Leukemia & Lymphoma ◽

10.3109/10428194.2013.838764 ◽

2013 ◽

Vol 55 (6) ◽

pp. 1332-1336 ◽

Cited By ~ 5

Author(s):

Rebecca B. Klisovic ◽

William Blum ◽

Zhongfa Liu ◽

Zhiliang Xie ◽

Cheryl Kefauver ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase I ◽

Ribonucleotide Reductase ◽

Myeloid Leukemia ◽

Phase I Study ◽

High Dose ◽

High Dose Cytarabine ◽

Phase I study of liposomal daunorubicin in relapsed and refractory acute myeloid leukemia

Oncology Reports ◽

10.3892/or.10.4.915 ◽

2003 ◽

Cited By ~ 1

Author(s):

Ralf Bieker ◽

Christian Lerchenmüller ◽

Jürgen Wehmeyer ◽

Hubert Serve ◽

Rolf Mesters ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase I ◽

Myeloid Leukemia ◽

Phase I Study ◽

Liposomal Daunorubicin ◽

Results of a Phase I Study with Mb-IL21 Ex Vivo Expanded NK Cells (FC21-NK) for Patients with Refractory Acute Myeloid Leukemia

Transplantation and Cellular Therapy ◽

10.1016/s2666-6367(21)00106-8 ◽

2021 ◽

Vol 27 (3) ◽

pp. S77-S78

Author(s):

Stefan O. Ciurea ◽

Jolie Schafer ◽

Piyanuch Kongtim ◽

Julianne Chen ◽

Doris Soebbing ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase I ◽

Nk Cells ◽

Myeloid Leukemia ◽

Phase I Study ◽

Ex Vivo ◽

Phase I study of azacitidine and bortezomib in adults with relapsed or refractory acute myeloid leukemia

Leukemia & Lymphoma ◽

10.3109/10428194.2013.833333 ◽

2013 ◽

Vol 55 (6) ◽

pp. 1304-1308 ◽

Cited By ~ 16

Author(s):

Alison R. Walker ◽

Rebecca B. Klisovic ◽

Ramiro Garzon ◽

Larry J. Schaaf ◽

Kristina Humphries ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase I ◽

Myeloid Leukemia ◽

Phase I Study ◽

Haematology and Blood Transfusion / Hämatologie und Bluttransfusion - Acute Leukemias VIII ◽

Phase I Study of Liposomal Daunorubicin (DaunoXome) in Relapsed and Refractory Acute Myeloid Leukemia

10.1007/978-3-642-18156-6_33 ◽

2001 ◽

pp. 191-195

Author(s):

C. Lerchenmüller ◽

W. E. Berdel ◽

T. BÜchner

Keyword(s):

Acute Myeloid Leukemia ◽

Phase I ◽

Myeloid Leukemia ◽

Phase I Study ◽

Liposomal Daunorubicin ◽

A Phase I Study of Fludarabine, Cytarabine, and Oxaliplatin Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2014.01.009 ◽

2014 ◽

Vol 14 (5) ◽

pp. 395-400.e1 ◽

Cited By ~ 1

Author(s):

Apostolia Maria Tsimberidou ◽

Michael J. Keating ◽

Elias J. Jabbour ◽

Farhad Ravandi-Kashani ◽

Susan O'Brien ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase I ◽

Myeloid Leukemia ◽

Phase I Study ◽

A phase I study of the mitochondrial metabolism inhibitor CPI-613 in combination with high-dose ara-C (HDAC) and mitoxantrone for relapsed or refractory acute myeloid leukemia (AML).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.7028 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 7028-7028

Author(s):

Timothy S. Pardee ◽

Kristin Stadelman ◽

Scott Isom ◽

Leslie R. Ellis ◽

Dmitriy P. Berenzon ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase I ◽

Myeloid Leukemia ◽

Phase I Study ◽

Mitochondrial Metabolism ◽

High Dose ◽

Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia

Frontiers in Oncology ◽

10.3389/fonc.2018.00369 ◽

2018 ◽

Vol 8 ◽

Cited By ~ 8

Author(s):

Prajwal Boddu ◽

Gautam Borthakur ◽

Mythili Koneru ◽

Xuelin Huang ◽

Kiran Naqvi ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase I ◽

Myeloid Leukemia ◽

Phase I Study ◽

Initial Report ◽